INFINIUM

Infinium Pharmachem Share Price

 

 

Start SIP in INFINIUM

Start SIP

Performance

  • Low
  • ₹240
  • High
  • ₹240
  • 52 Week Low
  • ₹214
  • 52 Week High
  • ₹337
  • Open Price₹240
  • Previous Close₹242
  • Volume500

Investment Returns

  • Over 1 Month -9.17%
  • Over 3 Month -5.85%
  • Over 6 Month -16.81%
  • Over 1 Year -25.76%

Smart Investing Starts Here Start SIP with Infinium Pharmachem for Steady Growth!

Invest Now

Infinium Pharmachem Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 41
  • PEG Ratio
  • -
  • Market Cap Cr
  • 334
  • P/B Ratio
  • Average True Range
  • 8.99
  • EPS
  • 6.45
  • Dividend Yield
  • 0
  • MACD Signal
  • -4.05
  • RSI
  • 47.15
  • MFI
  • 43.41

Infinium Pharmachem Financials

Infinium Pharmachem Technicals

EMA & SMA

Current Price
₹239.80
-2.2 (-0.91%)
pointer
  • Bearish Moving Average 14
  • Bullish Moving Average 2
  • 20 Day
  • ₹243.98
  • 50 Day
  • ₹250.05
  • 100 Day
  • ₹257.01
  • 200 Day
  • ₹262.62

Resistance and Support

242 Pivot Speed
  • R3 242.00
  • R2 242.00
  • R1 242.00
  • S1 242.00
  • S2 242.00
  • S3 242.00

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Infinium Pharmachem Ltd has an operating revenue of Rs. 375.42 Cr. on a trailing 12-month basis. An annual revenue growth of 15% is outstanding, Pre-tax margin of 7% is okay, ROE of 7% is fair but needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 78 which is a FAIR score but needs to improve its earnings, a RS Rating of 46 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C which is evident from recent supply seen, Group Rank of 48 indicates it belongs to a fair industry group of Comml Svcs-Healthcare and a Master Score of C is fair but needs to improve. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Infinium Pharmachem Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-13 Quarterly Results
2025-08-21 Others To consider other business matters. issue in the ratio of 1:1 of Rs. 10/-.
2025-05-28 Audited Results & Others To consider other business matters. (Revised) issue in the ratio of 1:1 of Rs. 10/-.
2024-11-14 Quarterly Results & Others To consider other business matters. issue in the ratio of 1:1 of Rs. 10/-.
2024-05-29 Audited Results
Date Purpose Remarks
2023-09-13 Bonus Rs.0.00 issue in the ratio of 1:1 of Rs. 10/-.

Infinium Pharmachem F&O

Infinium Pharmachem Shareholding Pattern

59.91%
37.21%
2.88%

About Infinium Pharmachem

  • NSE Symbol
  • INFINIUM
  • BSE Symbol
  • Managing Director
  • Mr. Sanjaykumar Viththalbhai Patel
  • ISIN
  • INE0MRE01011

Similar Stocks to Infinium Pharmachem

Infinium Pharmachem FAQs

Infinium Pharmachem share price is ₹239 As on 05 December, 2025 | 11:07

The Market Cap of Infinium Pharmachem is ₹333.7 Cr As on 05 December, 2025 | 11:07

The P/E ratio of Infinium Pharmachem is 41 As on 05 December, 2025 | 11:07

The PB ratio of Infinium Pharmachem is 5.3 As on 05 December, 2025 | 11:07

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23